サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1390555

脊椎生物製剤市場レポート：製品タイプ、手術タイプ、エンドユーザー、地域別、2023年～2028年

Spine Biologics Market Report by Product, Surgery Type, End User, and Region 2023-2028
出版日: | 発行: IMARC | ページ情報: 英文 144 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
脊椎生物製剤市場レポート：製品タイプ、手術タイプ、エンドユーザー、地域別、2023年～2028年
出版日: 2023年11月24日
発行: IMARC
ページ情報: 英文 144 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

概要

脊椎生物製剤の世界市場規模は2022年に20億米ドルに達しました。今後、IMARC Groupは、市場は2028年までに25億米ドルに達し、2022年から2028年にかけて3.79%の成長率（CAGR）を示すと予測しています。

脊椎生物製剤は、活性細胞プロセスを通じて周辺環境を変化させる材料です。それらは成長と分化を促進し、傷害の修復と治癒を助ける。また、一次手術や追加手術の頻度を減らし、軟部組織の破壊を減少させる。現在、多種多様な脊椎生物製剤が従来の治療に代わるものとして使用されています。例えば、ペディクルスクリューやロッドは脊椎固定術に応用され、脊椎を安定させることで治癒を促進します。さらに、絶え間ない進歩により、軟骨や骨構造の修復と再生が促進されています。

脊椎生物製剤市場の動向：

脊椎固定術は、脊椎の外傷、腫瘍、変性疾患の治療ツールとして利用されています。しかし、その治療成績が悪いと、患者に深刻な合併症を引き起こす可能性があります。このことは、急性および慢性疾患の患者数が大幅に増加していることと相まって、世界中の脊椎生物製剤の使用にプラスの影響を与えている重要な要因の1つとなっています。脊椎生物製剤は細胞レベルで癒合に影響を与え、症状のある変形や不安定性の治療において関節置換術を成功させるのに役立ちます。さらに、世界的に老年人口が増加しており、筋骨格系の疾患にかかりやすくなっています。このことは、整形外科疾患の有病率の増加とともに、脊椎生物製剤の世界の需要を刺激しています。これとは別に、非外科的手術に対する需要の高まりが、低侵襲腰椎手術における脊椎生物製剤の使用を後押ししています。脊椎生物製剤はまた、金属製ハードウェアの代替品として、また個々の天然骨移植片や同種移植片としても支持を集めています。さらに、所得水準の上昇によりヘルスケアサービスへのアクセスが増加していることも、市場の成長に寄与しています。

本レポートで扱う主な質問

  • 脊椎生物製剤の世界市場規模は？
  • 2023年～2028年の世界の脊椎生物製剤市場の予想成長率は？
  • 脊椎生物製剤の世界市場を牽引する主要因は何か？
  • COVID-19が脊椎生物製剤の世界市場に与えた影響は？
  • 脊椎生物製剤の世界市場の製品別区分は？
  • 脊椎生物製剤の世界市場における手術タイプ別の区分は？
  • 脊椎生物製剤の世界市場のエンドユーザー別区分は？
  • 脊椎生物製剤の世界市場における主要地域は？
  • 脊椎生物製剤の世界市場における主要プレーヤー/企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 脊椎生物製剤の世界市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：製品別

  • 脊椎移植片
    • 市場動向
    • 主要セグメント
      • 機械加工骨移植片
      • 脱灰骨マトリックス
    • 市場予測
  • 骨移植代替物
    • 市場動向
    • 主要セグメント
      • 骨形態形成タンパク質
      • 合成骨移植片
    • 市場予測
  • 細胞ベースマトリックス
    • 市場動向
    • 市場予測

第7章 市場内訳：手術タイプ別

  • 脊椎開放手術
    • 市場動向
    • 市場予測
  • 低侵襲脊椎手術
    • 市場動向
    • 市場予測

第8章 市場内訳：エンドユーザー別

  • 病院
    • 市場動向
    • 市場予測
  • 外来医療センター
    • 市場動向
    • 市場予測
  • 脊椎外科センター
    • 市場動向
    • 市場予測
  • 整形外科クリニック
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第9章 市場内訳：地域別

  • 北米
    • 米国
      • 市場動向
      • 市場予測
    • カナダ
      • 市場動向
      • 市場予測
  • アジア太平洋
    • 中国
      • 市場動向
      • 市場予測
    • 日本
      • 市場動向
      • 市場予測
    • インド
      • 市場動向
      • 市場予測
    • 韓国
      • 市場動向
      • 市場予測
    • オーストラリア
      • 市場動向
      • 市場予測
    • インドネシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 欧州
    • ドイツ
      • 市場動向
      • 市場予測
    • フランス
      • 市場動向
      • 市場予測
    • 英国
      • 市場動向
      • 市場予測
    • イタリア
      • 市場動向
      • 市場予測
    • スペイン
      • 市場動向
      • 市場予測
    • ロシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • ラテンアメリカ
    • ブラジル
      • 市場動向
      • 市場予測
    • メキシコ
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 中東・アフリカ
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第10章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第13章 価格分析

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Arthrex Inc
    • Alphatec Holdings Inc.
    • Exactech Inc
    • Johnson & Johnson
    • Medtronic plc
    • NuVasive Inc
    • Orthofix Medical Inc.
    • Stryker Corporation
    • Wright Medical Group N.V.
    • Zimmer Biomet
図表

List of Figures

  • Figure 1: Global: Spine Biologics Market: Major Drivers and Challenges
  • Figure 2: Global: Spine Biologics Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Spine Biologics Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Spine Biologics Market: Breakup by Product (in %), 2022
  • Figure 5: Global: Spine Biologics Market: Breakup by Surgery Type (in %), 2022
  • Figure 6: Global: Spine Biologics Market: Breakup by End User (in %), 2022
  • Figure 7: Global: Spine Biologics Market: Breakup by Region (in %), 2022
  • Figure 8: Global: Spine Biologics (Spinal Allografts) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 9: Global: Spine Biologics (Spinal Allografts) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 10: Global: Spine Biologics (Bone Graft Substitutes) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: Spine Biologics (Bone Graft Substitutes) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: Spine Biologics (Cell Based Matrix) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: Spine Biologics (Cell Based Matrix) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: Spine Biologics (Open Spine Surgery) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: Spine Biologics (Open Spine Surgery) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Spine Biologics (Minimally Invasive Spine Surgery) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Spine Biologics (Minimally Invasive Spine Surgery) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: Spine Biologics (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: Spine Biologics (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: Spine Biologics (Ambulatory Care Centers) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: Spine Biologics (Ambulatory Care Centers) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: Spine Biologics (Spinal Surgery Centers) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: Spine Biologics (Spinal Surgery Centers) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: Global: Spine Biologics (Orthopedic Clinics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: Global: Spine Biologics (Orthopedic Clinics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: Global: Spine Biologics (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: Global: Spine Biologics (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: North America: Spine Biologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: North America: Spine Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: United States: Spine Biologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: United States: Spine Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: Canada: Spine Biologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: Canada: Spine Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: Asia-Pacific: Spine Biologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: Asia-Pacific: Spine Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: China: Spine Biologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: China: Spine Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: Japan: Spine Biologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: Japan: Spine Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: India: Spine Biologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: India: Spine Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: South Korea: Spine Biologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: South Korea: Spine Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: Australia: Spine Biologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: Australia: Spine Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: Indonesia: Spine Biologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: Indonesia: Spine Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: Others: Spine Biologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: Others: Spine Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: Europe: Spine Biologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: Europe: Spine Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: Germany: Spine Biologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: Germany: Spine Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: France: Spine Biologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: France: Spine Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: United Kingdom: Spine Biologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: United Kingdom: Spine Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: Italy: Spine Biologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: Italy: Spine Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: Spain: Spine Biologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: Spain: Spine Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: Russia: Spine Biologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: Russia: Spine Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: Others: Spine Biologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: Others: Spine Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: Latin America: Spine Biologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: Latin America: Spine Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: Brazil: Spine Biologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: Brazil: Spine Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: Mexico: Spine Biologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 71: Mexico: Spine Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 72: Others: Spine Biologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 73: Others: Spine Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 74: Middle East and Africa: Spine Biologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 75: Middle East and Africa: Spine Biologics Market: Breakup by Country (in %), 2022
  • Figure 76: Middle East and Africa: Spine Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 77: Global: Spine Biologics Industry: SWOT Analysis
  • Figure 78: Global: Spine Biologics Industry: Value Chain Analysis
  • Figure 79: Global: Spine Biologics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Spine Biologics Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Spine Biologics Market Forecast: Breakup by Product (in Million US$), 2023-2028
  • Table 3: Global: Spine Biologics Market Forecast: Breakup by Surgery Type (in Million US$), 2023-2028
  • Table 4: Global: Spine Biologics Market Forecast: Breakup by End User (in Million US$), 2023-2028
  • Table 5: Global: Spine Biologics Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 6: Global: Spine Biologics Market: Competitive Structure
  • Table 7: Global: Spine Biologics Market: Key Players
目次
Product Code: SR112023A4333

Abstract

The global spine biologics market size reached US$ 2.0 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 2.5 Billion by 2028, exhibiting a growth rate (CAGR) of 3.79% during 2022-2028.

Spine biologics are materials that alter the surrounding environment through active cellular processes. They promote growth and differentiation and aid in the repair and healing of an injury. They also reduce the frequency of primary or additional surgical procedures and decrease the disruption of soft tissue. At present, a wide variety of spine biologics are used as an alternative to conventional treatments. For instance, pedicle screws and rods find application in a spine fusion procedure to provide spinal stabilization, thereby promoting healing. Moreover, continuous advancements are promoting the repair and regeneration of cartilaginous and bony structures.

Spine Biologics Market Trends:

Spine fusion is utilized as a tool in the treatment of spine trauma, tumors, and degenerative disorders. However, its poor outcomes can lead to serious complications among patients. This, in confluence with a significant increase in the number of individuals with acute and chronic conditions represents one of the key factors positively influencing the use of spine biologics around the world. Spine biologics impact fusion at the cellular level, which helps achieve successful arthrodesis in the treatment of symptomatic deformity or instability. Moreover, there is a rise in the geriatric population globally, which is more susceptible to musculoskeletal conditions. This, along with the growing prevalence of orthopedic conditions, is catalyzing the demand for spine biologics worldwide. Apart from this, the escalating demand for non-surgical procedures is encouraging the use of spinal biologics in minimally invasive lumbar surgeries. Spine biologics are also gaining traction as a replacement for metal hardware and in individual natural bone grafts or allografts. Furthermore, the growing access to healthcare services on account of inflating income levels is contributing to market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global spine biologics market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, surgery type and end user.

Breakup by Product:

Spinal Allografts

Machined Bones Allograft

Demineralized Bone Matrix

Bone Graft Substitutes

Bone Morphogenetic Proteins

Synthetic Bone Grafts

Cell Based Matrix

Breakup by Surgery Type:

Open Spine Surgery

Minimally Invasive Spine Surgery

Breakup by End User:

Hospitals

Ambulatory Care Centers

Spinal Surgery Centers

Orthopedic Clinics

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Arthrex Inc, Alphatec Holdings Inc., Exactech Inc, Johnson & Johnson, Medtronic plc, NuVasive Inc, Orthofix Medical Inc., Stryker Corporation, Wright Medical Group N.V. and Zimmer Biomet.

Key Questions Answered in This Report

  • 1. How big is the global spine biologics market?
  • 2. What is the expected growth rate of the global spine biologics market during 2023-2028?
  • 3. What are the key factors driving the global spine biologics market?
  • 4. What has been the impact of COVID-19 on the global spine biologics market?
  • 5. What is the breakup of the global spine biologics market based on the product?
  • 6. What is the breakup of the global spine biologics market based on the surgery type?
  • 7. What is the breakup of the global spine biologics market based on the end user?
  • 8. What are the key regions in the global spine biologics market?
  • 9. Who are the key players/companies in the global spine biologics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Spine Biologics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Spinal Allografts
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Machined Bones Allograft
      • 6.1.2.2 Demineralized Bone Matrix
    • 6.1.3 Market Forecast
  • 6.2 Bone Graft Substitutes
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Bone Morphogenetic Proteins
      • 6.2.2.2 Synthetic Bone Grafts
    • 6.2.3 Market Forecast
  • 6.3 Cell Based Matrix
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Surgery Type

  • 7.1 Open Spine Surgery
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Minimally Invasive Spine Surgery
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Ambulatory Care Centers
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Spinal Surgery Centers
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Orthopedic Clinics
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Arthrex Inc
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 SWOT Analysis
    • 14.3.2 Alphatec Holdings Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Exactech Inc
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Johnson & Johnson
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Medtronic plc
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 NuVasive Inc
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Orthofix Medical Inc.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Stryker Corporation
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Wright Medical Group N.V.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 SWOT Analysis
    • 14.3.10 Zimmer Biomet
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis